Samalizumab (ALXN 6000) is a humanized monoclonal antibody engineered to selectively target and bind to CD200, effectively inhibiting its interaction with the CD200 receptor (CD200R). This antibody is utilized in the study of multiple myeloma and B-cell chronic lymphocytic leukemia, offering a valuable tool for researchers exploring the pathophysiological roles and therapeutic potential of CD200-CD200R signaling in these hematological malignancies.
Samalizumab (ALXN 6000) is a humanized monoclonal antibody engineered to selectively target and bind to CD200, effectively inhibiting its interaction with the CD200 receptor (CD200R). This antibody is utilized in the study of multiple myeloma and B-cell chronic lymphocytic leukemia, offering a valuable tool for researchers exploring the pathophysiological roles and therapeutic potential of CD200-CD200R signaling in these hematological malignancies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
